1 – 33 of 33
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity – The ARTSCAN 2 study
(
- Contribution to journal › Article
-
Mark
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
(
- Contribution to journal › Article
- 2020
-
Mark
Substantial intrinsic variability in chemoradiosensitivity of newly established anaplastic thyroid cancer cell-lines
(
- Contribution to journal › Article
- 2016
-
Mark
Aspiration as a late complication after accelerated versus conventional radiotherapy in patients with head and neck cancer.
(
- Contribution to journal › Article
-
Mark
Wound-healing factors can prime head and neck cancer cells to increase their tumor-forming capacity.
2016) In Laryngoscope(
- Contribution to journal › Article
-
Mark
Low-dose rate brachytherapy with I-125 seeds has an excellent 5-year outcome with few side effects in patients with low-risk prostate cancer
(
- Contribution to journal › Article
- 2015
-
Mark
A prospective study of positron emission tomography for evaluation of neck node response 6 weeks after radiotherapy in patients with head and neck squamous cell carcinoma.
2015) In Head and Neck(
- Contribution to journal › Article
-
Mark
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
(
- Contribution to journal › Article
-
Mark
Anti- or pro-proliferation - Conditional options for TGF-α and cetuximab in head and neck squamous cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer.
2015) In European Journal of Nuclear Medicine and Molecular Imaging(
- Contribution to journal › Article
- 2014
-
Mark
Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma.
(
- Contribution to journal › Article
-
Mark
Radiotherapy response in head and neck cancer - evaluation of the primary tumour site
(
- Contribution to journal › Article
-
Mark
Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up
(
- Contribution to journal › Article
-
Mark
Radiation-induced trismus in the ARTSCAN head and neck trial.
(
- Contribution to journal › Article
- 2013
-
Mark
Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3
(
- Contribution to journal › Article
- 2012
-
Mark
Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts
(
- Contribution to journal › Article
-
Mark
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
(
- Contribution to journal › Article
-
Mark
The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
(
- Contribution to journal › Article
-
Mark
No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.
(
- Contribution to journal › Article
- 2008
-
Mark
Chemorefractory rhabdomyosarcoma treated with radiotherapy, bevacizumab, statins and surgery and maintenance with bevacizumab and chemotherapy.
(
- Contribution to journal › Article
- 2007
-
Mark
2-deoxy-2-[F-18]fluoro-D-glucose uptake and correlation to intratumoral heterogeneity
(
- Contribution to journal › Article
- 2006
-
Mark
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
(
- Contribution to journal › Article
-
Mark
Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays
(
- Contribution to journal › Article
-
Mark
Recombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma.
(
- Contribution to journal › Article
- 2004
-
Mark
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
(
- Contribution to journal › Article
- 2002
-
Mark
FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma.
(
- Contribution to journal › Article
- 2001
-
Mark
Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas
(
- Contribution to journal › Article
- 1995
-
Mark
Radiation effects on S-phase duration, labelling index, potential doubling time and DNA distribution in head and neck cancer xenografts
(
- Contribution to journal › Article
-
Mark
A Phase I/II Evaluation of Metoclopramide as a Radiosensitiser in Patients with Inoperable Squamous Cell Carcinoma of the Lung
(
- Contribution to journal › Article
-
Mark
Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
- 1992
-
Mark
Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation
(
- Contribution to journal › Article